2/21/2013

Researchers tracked more than 2,800 patients with venous thromboembolism and found that treatment with the anticoagulant dabigatran was associated with a lower risk of major bleeding compared with warfarin. The study appeared in the New England Journal of Medicine.

Full Story:
WebMD

Related Summaries